Hopkins Washington Life Medicine LAB has partnered with Kangjin Biotechnology to showcase their collaborative innovation in the global health industry at the China International Import Expo (CIIE)

 （Home Stadium Panorama）

At the 8th China International Import Expo (CIIE), the Hopkins Washington Life Medicine Laboratory sparked a wave of technological cooperation, signing in-depth strategic cooperation agreements with leading enterprises such as Hong Kong Kangjin Biotechnology and Australia AULINDA, embarking on a new journey of "Open Chain World · Cooperation Creates the Future". Adhering to the core philosophy of "Solving Health Problems with Nutrition", the laboratory leverages the CIIE platform to accelerate the transformation of cutting-edge scientific research achievements into practical applications, promoting the collaborative advancement of the global health industry.

 (Laboratory raw material technology display)

At this year's China International Import Expo (CIIE), the laboratory showcased six core raw material technologies, including glutathione yeast, PQQ and mitochondrial energy, tetrahydrokempesene multifunctionality, ergothioneine anti-aging properties, and liposome controlled-release technology. These innovations stem from the lab's decades of dedicated research in cellular microbiology and nutritional science. The team comprises world-class experts, with each product rigorously adhering to natural science standards and implementing full-process supervision mechanisms to ensure health benefits from the source.

(Professional visitors actively communicate at the laboratory booth)

The laboratory has participated in the China International Import Expo (CIIE) for several consecutive years. In 2025, its booth highlights the latest breakthroughs in brain health. Partner Kangjin Biotechnology launches the 'JOURTHON Brain Health Soft Capsule' for the first time, featuring ergothioneine, PQQ, and α-GPC. Scientifically validated to enhance cognitive vitality, this product caters to the needs of people across all age groups.

 (Kangjin Biotechnology launches new brain-focused products)

In the realm of collaboration,Hopkins Washington Life Medicine Lab and Kangjin Biotechnology have forged a deep strategic partnership. Senior executives from both organizations jointly announced the initiative, with Kangjin Chairman Su Yizhe emphasizing that this collaboration will jointly explore cutting-edge life sciences and facilitate the commercialization of advanced technological achievements. He firmly believes this partnership will not only provide consumers with more precise and innovative health solutions, but also drive biotechnology development through technological and industrial synergy, enabling every household to enjoy a healthier lifestyle powered by biotech innovation.

Mr.Hu Bo, co-founder of the laboratory, also expressed the vision of strategic cooperation with Kangjin Biotechnology, and the two sides will work together to start the innovation journey in the field of health research.

(Lab and Kangjin Biotechnology signing ceremony group photo)

During the China International Import Expo (CIIE), the laboratory forged a strategic partnership with Aulinda, a leading Australian health technology company, in the healthcare sector. This collaboration has enriched the CIIE's theme' New Era · Shared Future' with practical, open-ended initiatives.

 (Laboratory signs contract with Aulinda)

The lab will empower partners through its proprietary HWLL certification system, achieving full-chain collaboration (including production oversight and customs compliance), while strengthening long-term co-creation via the CIIE Joint Exhibition Program.

In the future, the Hopkins Washington Life Medicine Laboratory in the United States plans to set up subsidiary service institutions in Shanghai and Wuhan, China, in order to promote the process of product certification and marketization, and uphold the scientific spirit to share innovative health achievements with global families.